[1]
2026. To Hold or Not to Hold? Periprocedural Management of Glucagon-like Peptide-1 Receptor‑based Agonists (GLP‑1ra) in Patients with Diabetes and Obesity. Canadian Diabetes & Endocrinology Today. 4, 1 (mai 2026), 26–34. DOI:https://doi.org/10.58931/cdet.2026.4152.